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Abstract
Salt-inducible kinase 3 (SIK3), an AMP-activated protein kinase-related kinase, is induced in the murine liver after the
consumption of a diet rich in fat, sucrose, and cholesterol. To examine whether SIK3 can modulate glucose and lipid
metabolism in the liver, we analyzed phenotypes of SIK3-deficent mice. Sik3
2/2 mice have a malnourished the phenotype
(i.e., lipodystrophy, hypolipidemia, hypoglycemia, and hyper-insulin sensitivity) accompanied by cholestasis and
cholelithiasis. The hypoglycemic and hyper-insulin-sensitive phenotypes may be due to reduced energy storage, which is
represented by the low expression levels of mRNA for components of the fatty acid synthesis pathways in the liver. The
biliary disorders in Sik3
2/2 mice are associated with the dysregulation of gene expression programs that respond to
nutritional stresses and are probably regulated by nuclear receptors. Retinoic acid plays a role in cholesterol and bile acid
homeostasis, wheras ALDH1a which produces retinoic acid, is expressed at low levels in Sik3
2/2 mice. Lipid metabolism
disorders in Sik3
2/2 mice are ameliorated by the treatment with 9-cis-retinoic acid. In conclusion, SIK3 is a novel energy
regulator that modulates cholesterol and bile acid metabolism by coupling with retinoid metabolism, and may alter the size
of energy storage in mice.
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Introduction
Cholesterol has diverse functions in eukaryotes, e.g., as a cell
membrane component and a source of hormones and bile acid
(BA). Dysregulation of cholesterol metabolism is involved in a
variety of disease, such as dyslipidemia, cardiovascular disease,
and obesity [1]. The liver X receptor (LXR) is a nuclear receptor
that binds to target DNA elements by forming a heterodimer
complex with the retinoid X receptor (RXR) [2,3]. Excess
cholesterol is sensed by LXRs as their ligands, and active LXR-
RXR complexes promote the gene expression of cholesterol-
catabolic enzymes (e.g., cytochrome P450 family 7A [CYP7A],
which catabolizes cholesterol to BA in the liver) and cholesterol
transporters, e.g., ATP-cassette G5 (ABCG5) and G8 in the liver
and ABCA1 in the peripheral tissues. LXR also up-regulates
hepatic fatty acid (FA) synthesis by inducing the expression of
sterol regulatory element-binding protein 1c (SREBP1c) [4].
BA is also multifunctional molecules with a role in the digestive
tract. The impairment of bile flow by bile duct lesions and
cholelithiasis causes the retention of excess amounts of BA
(cholestasis) and leads to chronic hepatitis. The farnesoid X
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RXR, and up-regulates gene expression to lower the level of BA in
the liver [5] by inducing the bile salt export pump (BSEP) and
small heterodimer partner (SHP), which suppresses Cyp7a expres-
sion [6]. Excess levels of the BA pool also enhance energy
expenditure and suppression of FA synthesis [7]. Meanwhile, a
reduction of the BA pool by the activation of FXR induces obesity
and hyperglycemia [8], suggesting that cholesterol-BA homeostasis
is important for lipid and glucose metabolism.
9-Cis retinoic acid (9-cis-RA), an endogenous RXR ligand, is
synthesized from vitamin A [9]. Vitamin A deficiency or RXR
inhibition results in reduced LXR and FXR activity, which can
lead to hepatic cholestasis [1]. Conversely, dysregulation of the
metabolism of vitamin A to 9-cis-RA induces resistance to diet-
induced obesity and type 2 diabetes in mice [10]. Because vitamin
A absorption by enterocytes requires BA, BA homeostasis is tightly
coupled with vitamin A metabolism [11].
Salt-inducible kinase (SIK), a member of the 59-AMP-activated
protein kinase (AMPK)-related kinase family, has 3 isoforms and
regulates gene expression in various cells [12]. For example, SIK1
inhibits steroidogenic gene expression in the adrenal glands and
gluconeogenic gene expression programs in the liver by repressing
the cAMP response element (CRE)-binding protein (CREB)
transcription factor [13,14] [15–16]. Meanwhile, SIK2 suppresses
insulin-dependent thermogenic gene expression in brown adipose
tissue [17]. In addition, in mice with a disrupted Sik2 gene,
downregulation of SIK2 expression confers resistance to oxidative
stresses after brain ischemia [18] and enhances melanogenesis in
melanocytes after ultraviolet irradiation [19,20]. These SIK2-
dependent physiological events are also explained by the
modulation of CREB activity.
When CREB is phosphorylated at Ser133 in its kinase-inducible
domain by upstream activating kinases, such as protein kinase A
(PKA) and Ca
2+/calmodulin-dependent kinase I/IV (CaMKI/
IV), it recruits coactivators, e.g., CREB-binding protein and p300
and induces CRE-dependent transcription [21]. The other CREB-
specific coactivator, i.e., CREB regulated transcription coactivator
(CRTC or TORC), also activates CREB in response to PKA and
CaMKI/IV [22,23]. In contrast to CREB, CRTC is inactivated
by phosphorylation and is sequestered in the cytoplasm of
unstimulated cells [24]. SIK1 and SIK2 are among the CRTC
kinases that are involved in SIK-mediated inhibition of CREB
[25]. Recently, p300 was also reported to be a mediator of SIK
signaling in hepatocytes [26]. SIK2 inhibits the coactivation
activity of p300 by phosphorylating Ser89, which prevents
carbohydrate response element-binding protein-dependent hepat-
ic steatosis in mice.
In addition to CREB and p300 repression, SIK1 induces
hypertrophic action in the muscles by inhibiting class 2a histone
deacetylase (HDAC) and then upregulating MEF2C transcription
activity [27]. Recently, SIK2 was also found to inactivate class 2a
HDAC in Drosophila, which results in the accumulation of FA in
the fat body of insects and confers resistance to starvation [28].
These observations suggest that like AMPK, SIK1 and SIK2 may
play important roles in the regulation of metabolic or stress
responses.
SIK3 is also capable of regulating CREB activity in cultured
cells under overexpression [29] or in vitro conditions [30].
Recently, we found that mice with a disrupted Sik3 gene showed
dwarfism because of the impairment of chondrocyte hypertrophy
during skeletal development, which was accompanied by disin-
activation of class 2a HDAC in the cartilage [31]. However, SIK3
phenotypes in adult mice, especially those related to energy
metabolism, have not yet been elucidated.
Here, we report the induction of Sik3 mRNA in the mouse liver
after the consumption of a high-fat diet supplemented with excess
cholesterol. Phenotyping of adult Sik3
2/2 mice suggested that
SIK3 is a novel regulator of glucose-lipid metabolism in the liver
that maintains cholesterol-BA homeostasis along with the regula-
tion of lipid storage size.
Results
Sik3
2/2 Mice Exhibit a Lipodystrophic Phenotype
Factors affecting body size and longevity in model organisms,
such as Caenorhabditis elegans and Drosophila, often play important
roles in the regulation of energy metabolism in mammals. The
same may hold true for SIK. The C. elegans kin-29 (ortholog of SIK)
mutant shows increased longevity and small body size [32], while
Drosophila expressing reduced levels of SIK2 acquired resistance to
oxidative stress and starvation [33]. We also found that Sik2
2/2
mice show resistance to brain ischemia [18]; however, Sik2
2/2
mice are apparently normal in terms of body weight regulation
[19].
To reevaluate individual SIK isoforms in the regulation of
nutrient metabolism, normal C57BL/6J mice were fed with a
variety of diets, and we examined their mRNA levels were
examined. Interestingly, Sik3 mRNA was strongly induced in the
livers of the mice fed a high-fat/high-sucrose/high-cholesterol
(HF/HS/HChol) diet. This up-regulation was accompanied by
the induction of mRNA for metabolic enzymes such as FA synthase
(Fasn) and Cyp7a (Figure 1A). These results led us to investigate of
the metabolic profiles of Sik3 knockout mice [31].
Although Sik3
2/2 mice were indistinguishable from wild-type
mice just after birth, most of the knockout (KO) mice died on the
first day (Figure S1A). Caesarean delivery failed to prevent the
early death of Sik3
2/2 mice. Because Sik3
2/2 mice had skeletal
abnormalities, their early death was probably due to respiratory
failure caused by thoracic dystrophy [31]. However, the transgenic
expression of SIK3 in the cartilage of Sik3
2/2 mice failed to
prevent their early death despite its correction of the skeletal
abnormalities (no Sik3
2/2 mouse survived out of seventeen
weanling mice derived from the matings between Sik3
2/2 females
and Sik3
2/2 :: Col11a2-hSik3 males).
The Sik3
2/2 mice that survived the first day could be weaned
(Figure S1B), but their body weight was obviously less than that of
the wild-type mice (male; Figure 1B). This was also the case with
the females. We dissected 1-year-old mice and found that the lean
phenotype of Sik3
2/2 mice was attributed to the liver and adipose
tissues, especially mesenteric and perirenal fat (Figure 1C and D).
Small but substantial amounts of gonadal and subcutaneous fat
and brown adipose tissue were observed in Sik3
2/2 mice.
Hematoxylin and eosin (HE) staining suggested that the small fat
pads were probably due to the small size of the adipocytes
(Figure 1E and S1C). The low levels of liver TG in Sik3
2/2 mice
might have prevented the development of fatty liver (Figure 1E
and F), while total cholesterol levels were low in the serum of
Sik3
2/2 mice. Fast protein liquid chromatography (FPLC) analysis
of serum lipids indicated that Sik3
2/2 mice exhibited hypo-high
density lipoprotein (HDL) cholesterolemia (Figure 1G).
To elucidate the causes of the lipodystrophic phenotype of
Sik3
2/2 mice, we compared the energy balance between wild-type
and Sik3
2/2 mice. Sik3
2/2 mice consumed more food than the
wild-type mice (Figure 1H), while the rate of digestion and
absorption in the intestine appeared normal (Figure S1D). The
rectal temperature of Sik3
2/2 mice was higher than that of the
wild-type mice (Figure 1I), which might correlate with the high
levels of the O2 consumption (VO2: voluntary O2 consumption)
SIK3, a New Metabolic Regulator
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e37803observed in Sik3
2/2 mice (Figure 1J). The high respiratory
quotient (RQ) value of the Sik3
2/2 mice was well explained by the
insufficient fat storage followed by reduced fat utilization observed
in these mice (Figure 1K). These results suggested that the
lipodystrophic phenotype of Sik3
2/2 mice might be a result of
their high rates of energy consumption.
We also examined secondary parameters such as blood glucose
levels. In the fed condition, the Sik3
2/2 mice had slightly lower
Figure 1. Sik3
2/2 mice are lean, hypolipidemic, and hypoglycemic. (A) C57BL/6 mice (male: n=4) were fed various diets (HF, high fat; HS,
high sucrose; HChol, high cholesterol) for 2 weeks, and liver mRNA was examined by quantitative PCR. *, **, and *** indicate p,0.05, ,0.01, and
,0.001, respectively. Means and SEM are shown. (B) The body weight of male mice (n=6) was monitored. All data points show p,0.001. (C) One-
year-old male mice (n=5) were sacrificed (scale: 1 mm), and the indicated tissues were weighed (D). (E) Histology of liver and mesenteric fatty tissue
is shown. Each magnification is the same. (F) Cholesterol (Chol) and triglycerides (TG) in the liver and serum were measured (n=5). (G) Serum
cholesterol and TG were separated using FPLC. (H) The food consumption of each group (n=12). (I) Rectal temperature (n=12). (J) Oxygen
consumption (VO2, voluntarily O2 consumption) and (K) average respiratory quotient (RQ) during the day and night (n=5). (L) Mice (n=5) were fasted
and their blood glucose levels were monitored at the indicated time points. All data points show p,0.001. (M) After 4-h fasting, the serum levels of
insulin, leptin, free fatty acid (FFA), and ß-hydroxybutyrate were measured. (N) After 4-h fasting, glucose (1.5 g/kg) was intraperitoneally injected
(GTT, glucose tolerance test) and blood glucose levels were monitored (n=5). (O) After 24-h fasting, lactate (1.5 g/kg) was injected intraperitoneally
(LTT, lactate tolerance test; n=5).
doi:10.1371/journal.pone.0037803.g001
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decreased after fasting (Figure 1L). After a 4-h fast, the Sik3
2/2
mice had significantly lower serum insulin and leptin levels than
the wild-type mice (Figure 1M), while no obvious differences were
observed in free FA or ketone body (ß-hydroxybutyrate) levels.
Given the enhanced food-consumption of Sik3
2/2 mice, the
apparently enhanced insulin- and leptin-action may be restricted
to the peripheral tissues. Although we suspected thyrotoxicosis, the
levels of circulating thyroid hormones did not differ between the 2
genotypes (Figure S1E).
Sik3
2/2 mice exhibited enhanced glucose tolerance (GTT)
(Figure 1N). When Sik3
2/2 mice were treated with insulin (ITT),
their blood glucose levels decreased like those of the wild-type mice
(Figure S1F). Once the Sik3
2/2 mice were supplied exogenously
with an energy source, such as lactate (lactate tolerance test), they
were able to produce glucose efficiently (Figure 1O), suggesting
that the hypoglycemia of Sik3
2/2 mice may be due to a lack of
energy storage followed by an enhanced insulin response. This was
also the case under the high-fat diet feeding condition (Figure 2A–
J). Of particular note is that accumulation of cholesterol was
suppressed in the livers of Sik3
2/2 mice (Figure 2I), and the ratio
of LDL-cholesterol to HDL-cholesterol was decreased in the
serum of Sik3
2/2 mice with a reduction of TG content in the very
low-density lipoprotein (VLDL) fraction (Figure 2J).
Which tissue is responsible for the phenotypes of the Sik3
2/2
mice? To address this question, we measured the body weight of
heterozygous (Sik3
+/2 ) mice. The body weight curve of the
Sik3
+/2 mice overlapped with that of the wild-type mice (Figure
S2A). Curiously, the mRNA and protein levels of SIK3 in the
livers of Sik3
+/2 mice were as high as those in wild-type mice
(Figure S2B), though the specific levels of Sik3 mRNA did not
differ between parenchymal and non-parenchymal cells (Figure
S2C). Given that parenchymal cells are the major population of
the liver, we surmised that the liver, probably parenchymal cells,
may be one of the responsible tissues/cells for the phenotypes of
the Sik3
2/2 mice.
Mice with disrupted genes for Mark2 [34] or Mark3 [35], which
are other members of the AMPK family, have been found to be
resistant to diet-induced obesity due to enhanced glucose-
utilization in the brown adipose tissue. However, the mRNA
expression levels of genes related to energy expenditure, such as
Ppargc1a and Ucp1, in brown adipose tissue were not different
between wild-type and Sik3
2/2 mice.
Moreover, an in vitro adipocyte differentiation experiment using
gonadal fat indicated that the preadipocytes of Sik3
2/2 mice
possessed a higher capability to differentiate into adipocytes than
those from wild-type mice (Figure S2D), which might correlate
with the high serum level of adiponectin in Sik3
2/2 mice (Figure
S2E). Given the expression level of Sik3 mRNA (Figure S2B), we
surmised that the lipodystrophic phenotype of Sik3
2/2 mice might
be caused by the impairments of the liver rather than the adipose
tissues.
Signaling States in the Livers of Sik3
2/2 Mice
The gene expression profile of the liver (Figure 3A) indicated
that the pathway from glycolysis to FA synthesis was down-
regulated in Sik3
2/2 mice, while the glyconeogenic pathway was
up-regulated. Sik3
2/2 mice expressed high levels of Fgf21 mRNA,
suggesting an adaptive response to starvation; however, its
promoting pathway, i.e., the peroxisome proliferator-activated
receptor alpha (PPARa) pathway, was down-regulated. Lack of FA
storage and the uncoupling of FGF21 from the PPARa pathway in
Sik3
2/2 mice may result in the failure to induce ß-oxidation
followed by ketogenesis [36].
We also examined the state of signaling molecules. The high
level of PGC-1a protein in the liver of Sik3
2/2 mice was
accompanied by the dephosphorylation of CRTC2 (Figure 3B)
despite there being no significant difference in the status of CREB.
Interestingly, the level of another CRTC2 kinase, AMPK [15],
and of its activated phosphorylated form (pThr172) were also high
in the livers of Sik3
2/2 mice. Immunohistochemical analyses
revealed the enhanced accumulation of CRTC2 in the nuclei of
Sik3
2/2 mice hepatocytes (Figure 3C). In addition, HDAC5,
another SIK/AMPK substrate [37,38], also accumulated in the
nuclei of liver cells in Sik3
2/2 mice, suggesting that AMPK is
unable to compensate for the deficiency of SIK3 in hepatocytes.
Sik3
2/2 Mice are Unable to Adapt to Cholesterol
Adiponectin had been found to promote fat accumulation in
adipose tissues and to improve insulin sensitivity in leptin-resistant
mice [39], which could explain the hypoglycemic phenotype of
Sik3
2/2 mice, but not their lipodystrophy. What are the unknown
factors?Interestingly,little,ifany,changeswerefoundinthemRNA
levels of the cholesterol and BA metabolic genes in Sik3
2/2 mice
(Figure 3A) and irregular expression patterns were observed, i.e.,
ApoA1 and Abcg5 were up-regulated, while Cyp8b was strongly
suppressed.Moreover,hepaticSik3mRNAexpressionisinducedby
a high-fat diet supplemented with high-cholesterol (Figure 1A).
Therefore, we decided to examine effects of cholesterol (with fat) on
Sik3
2/2 mice by challenging the mice with a high-cholesterol diet
(HF/HS/HChol).
After 4 months, the wild-type mice developed fatty liver, while
the livers of Sik3
2/2 mice had surface asperity and turned yellow
(Figure 4A). HE staining revealed the enhanced formation of a
dilated canalicular structure in the livers of Sik3
2/2 mice (Fig 4B,
upper and lower left), and these structures were highly positive for
BSEP-immunoreactive signals (green signals in Figure 4B lower right).
Liver and serum lipid levels were increased after feeding with the
HF/HS/HChol diet; however, they were not significantly
different from the levels observed when wild-type and Sik3
2/2
mice were fed a chow diet (compare Figure 1F to Figure 4C). The
ratio of LDL-cholesterol to HDL-cholesterol in Sik3
2/2 mice was
reversed after feeding with the cholesterol-containing diet (com-
pare Figure 1G to Figure 4D), and was accompanied by an
increase in TG content in the LDL fraction in Sik3
2/2 mice.
The fluctuations in serum alanine amino transferase (ALT)
levels suggested that the livers of Sik3
2/2 mice were damaged soon
after feeding and lost their normal function, e.g., ALT production,
after 5 weeks (Figure 4E). While liver injury in the wild-type mice
progressed gradually, probably due to fatty liver, the degree of
latent liver injury after 4-month of receiving the high-cholesterol
diet was higher in Sik3
2/2 mice, possibly because of the higher
mRNA expression levels of inflammatory factors in the livers of
Sik3
2/2 mice (Figure 4F).
To focus on effects of cholesterol alone, Sik3
2/2 mice were
challenged with a high-cholesterol (2%) diet according to the
same schedule as the HF/HS/HChol diet. The liver abnormal-
ities of Sik3
2/2 mice were barely visible on the surface
(Figure 5A); however, a number of foci that were negative for
eosin-staining (Figure 5B, arrows) were detected in the livers of
Sik3
2/2 mice. These foci might be enriched in cholesterol
derivatives, because we observed strong autofluorescence in the
frozen sections (Figure 5B lower right), and the level of hepatic
cholesterol was higher in Sik3
2/2 mice than in wild-type mice
(Figure 5C). A small numbers of dilated canalicular structures
were again observed in the Sik3
2/2 mice liver (Figure 5B lower
left).
SIK3, a New Metabolic Regulator
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2/2 mice fed with the high-
cholesterol diet were almost the same as those of Sik3
2/2 mice fed
with the HF/HS/HChol diet. Liver injury in Sik3
2/2 mice
progressed gradually (Figure 5E), and we observed high mRNA
expression levels of inflammatory factors in the liver of Sik3
2/2
mice (Figure 5F).
Why were the livers of Sik3
2/2 mice injured after the
consumption of the high-cholesterol diet? Are there any hints to
explain the lipodystrophic phenotype of these mice? To address
these questions, we reevaluated blood biochemical markers for the
liver and biliary duct systems. Even when Sik3
2/2 mice were fed a
chow diet, their serum ALT levels gradually increased with age
(Figure 6A). However, the high-fat diet (as evidenced by the
dissection of a 30-week-old mouse) protected the livers of Sik3
2/2
mice from the injuries caused by aging as well as by fatty liver.
Conversely, once cholesterol is added to the diet, this protection
may become invalid. As the serum alkaline phosphatase (ALP) and
BA levels were continuously high in Sik3
2/2 mice, except when
under the high-fat diet, we hypothesized that the dysregulation of
BA metabolism followed by hepatic cholestasis (Figure 6B) might
be the cause of the hepatic injuries.
In addition, to test whether high levels of BA could suppress
body weight gain, the mice were fed a high-cholic acid (CA) diet
for 1 month. As shown in Figure 6C, the high-CA diet completely
suppressed the weight gain of wild-type mice and reduced the
body weight of Sik3
2/2 mice, suggesting that dysregulation of BA
metabolism might be one of the causes of the lipodystrophic
phenotype of Sik3
2/2 mice.
Sik3
2/2 Mice are Unable to Adapt to CA
To examine the details of the dysregulation of BA metabolism in
Sik3
2/2 mice, we dissected these mice. Their gallbladders of
Sik3
2/2 mice were enlarged, and their livers had become yellow-
brown (Figure 7A). HE staining identified hypertrophic hepato-
cytes with lipid droplets (Figure 7B). The gallbladders of Sik3
2/2
mice (Figure 7C) were accompanied by hyperplastic mucosal
epithelia (Figure 7E).
The volume of bile in the gallbladders of Sik3
2/2 mice was
large, but its color was light (Figure 7D). A good amount of bile
sand was also found in the gallbladders of Sik3
2/2 mice
(Figure 7D, right). Like FXR-KO mice [40], the deposition of
bile sand might be a result of the presence of cholesterol crystals
Figure 2. Sik3
2/2 mice are resistant to a high-fat diet. (A) A representative image of male mice after high-fat (60% of calories) feeding. Mice
(n=6) were fed with a high-fat diet for 12–30 weeks and their body weights were monitored every week (B). Means and SEM are shown. All data
points indicate p,0.001. (C) Representative photos of tissues (scale, 1 mm). (D) Tissue weights are shown. *, **, and *** indicate p,0.05, ,0.01, and
,0.001, respectively. (E) Levels of blood glucose, insulin, and leptin measured after 4-h fasting. (F) Glucose tolerance test (1.5 g/kg) performed after 4-
h fasting. (G) Cholesterol and triglyceride content in feces (n=3 cages). (H) Oxygen consumption (VO2, voluntarily O2 consumption) of each group
(n=6) was monitored. Respiration quotient (RQ) during the day and night. (I) Cholesterol (Chol) and triglycerides (TG) in the liver and serum were
measured (n=6). (J) Serum Chol and TG were separated using FPLC.
doi:10.1371/journal.pone.0037803.g002
Figure 3. Gene expression profile in the liver. (A) One-year-old male mice (n=5) were fasted for 4 h, and the liver mRNA levels were measured
using quantitative polymerase chain reaction (qPCR). Red and blue indicate the up- and down-regulated genes in Sik3
2/2 mice, respectively. +, fold
increase; -, fold decrease. The threshold is set at p=0.1. The values marked with an asterisk (*) were obtained using PCR-array kits (n=3). The
abbreviations for the genes and the PCR primers used are listed in Table S2. Mit, mitochondria; TCA, tricarboxylic acid cycle. (B) Intracellular signaling
molecules and their activation status in the liver were examined by western blot analysis. (C) Immunohistochemical analysis of SIK3 substrates (CRTC2
and HDAC5) in the liver.
doi:10.1371/journal.pone.0037803.g003
SIK3, a New Metabolic Regulator
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2/2 mice
(Figure 7F); this could have been caused by the decreased levels
of phospholipids followed by the reduced solubility of bile [41].
High serum BA and ALT levels were observed in Sik3
2/2
mice on the high-CA diet (Figure 7G). The levels of ALP and
total bilirubin were also high in Sik3
2/2 mice (Figure 7H). The
lipid droplets observed in the livers of Sik3
2/2 mice (Figure 7B)
might be composed of cholesterol because cholesterol, and not
TG, had accumulated in their livers (Figure 7I). The levels and
patterns of serum cholesterol and TG in Sik3
2/2 mice were also
abnormal (Figure 7J); notably, the levels of cholesterol in the
VLDL-LDL fraction of the wild-type mice was enhanced by CA
feeding, which was more obvious in Sik3
2/2 mice. Given the
severe phenotype caused by CA feeding, we surmised that
cholestasis might be the primary phenotype of Sik3
2/2 mice, and
this may then lead to or enhance the other phenotypes, e.g.,
lipodystrophy and dyslipidemia.
Because most of the Sik3
2/2 mice were dead on the day of birth
(Figure S1A), we examined the livers of embryos. As shown in
Figure S3A, hepatocytes in Sik3
2/2 embryos (E18.5) were not
normal; notably, the hepatocytes were of a variable size, and a
significant number of multinucleated hepatocytes were observed,
suggesting liver damages due to embryonic cholestasis. It was
partly true that the BA levels in the livers of Sik3
2/2 embryos were
higher than those of wild-type embryos (Figure S3B). However,
when the mice were born, the BA content in the liver of the wild-
type mice reached levels equivalent to that of Sik3
2/2 mice and
decreased thereafter, suggesting that hepatic cholestasis might
occur in Sik3
2/2 embryos, but it cannot explain the early death of
Sik3
2/2 mice. Alternatively, we suppose that Sik3
2/2 neonates
may unable to adapt their metabolism to the environmental
changes at birth.
Gene Expression Profile in the Livers of Sik3
2/2 Mice Fed
with Special Diets
We examined mRNA expression in the liver to elucidate the
mechanisms involved in the Sik3
2/2 phenotypes. As shown in
Table S1, the resistance to diet-induced obesity in Sik3
2/2 mice
might be explained by the low levels of lipogenic mRNA, e.g.,
Fasn and Scd1. Amelioration of hepatic injury in Sik3
2/2 mice
Figure 4. Sik3
2/2 mice are less tolerant to a cholesterol-containing high-fat diet. (A) Male mice were fed a high-fat and high-sucrose diet
supplemented with 2% cholesterol (HF/HS/HChol) for 4 months (12–30 weeks) and then sacrificed (n=6). (B) HE staining of the liver (sets at the upper
and lower left), BSEP-staining (lower right: BSEP is green and nuclei are blue (DAPI)). The magnification is the same in each set. (C) Cholesterol and TG
levels in the liver and serum were measured (n=6). *** indicates p,0.001. Means and SEM are shown. (D) FPLC analysis of serum lipids. (E) Serum
levels of alanine aminotransferase (ALT) were monitored at the indicated time points. ** indicates p,0.01. (F) Quantitative polymerase chain reaction
analysis of inflammatory molecules (tumor necrosis factor-a and STAT3) in the liver.
doi:10.1371/journal.pone.0037803.g004
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cholesterol (HmgCoAr) and BA (Cyp7a) synthesis.
However, the mRNA expression patterns of mice fed on the
high-cholesterol or high-CA diet could not explain the
pathogenesis of Sik3
2/2 mice, and some discrepancies remained.
When mice were fed with the high-cholesterol diet, no
significant difference in the mRNA levels of genes for
cholesterol synthesis, e.g., HmgCoAr, was observed between
wild-type and Sik3
2/2 mice. The level of Cyp7a (bile acid
synthesis) mRNA was also the same, despite the high expression
level of its repressor (Shp). Meanwhile, when the mice were fed
with the high-CA diet, Sik3
2/2 mice expressed lower levels of
Cyp7a mRNA than the wild-type mice, despite no changes in
the levels of Shp.
Here, we have to mention some of the problems associated with
these gene expression analyses. For example, the mice that were
fed the different diets were of different ages. In addition, the
special diets were suspected to produce secondary effects, such as
hepatic injury. Therefore, we decided to examine gene expression
during the acute phase.
Adaptive Gene Expression is Dysregulated in Sik3
2/2
Mice
To examine gene expression during the acute phase with a
biased diet, 12-week-old mice were fed either a high-cholesterol or
high-CA diet for 2 days or a high-fat diet for 2 weeks. As shown in
Figure 8A and S3A, the gene expression profile in the livers of
young mice under chow-diet feeding was different from that of
aged mice (Figure 3A), probably due to differences in the degree of
hepatic injury (Figure 6A). Under the acute phase condition, the
genes were categorized into 2 groups: (1) mRNA levels not affected
by the diets in Sik3
2/2 mice (e.g., Shp, Bsep, AbcG5, AbcA1, and
Fasn), and (2) mRNA levels that were irregularly affected (e.g.,
Cyp7a, Cyp8b, and Cyp27a) (Figure 8A and S4A). Strangely, Cyp7a
gene expression was lower in Sik3
2/2 mice than in wild-type mice,
despite the low expression levels of Shp.
The little or no expression of Cyp7a observed under the high-
cholesterol diet in Sik3
2/2 mice could be explained by LXR
dysfunction [3], while the low expression of Shp or Bsep [6] and
hypertrophic gallbladder [40] suggested FXR dysfunction. RXR is
activated by 9-cis-RA, which is synthesized from vitamin A [9],
Figure 5. Cholesterol accumulation in the livers of Sik3
2/2 mice after feeding with a high-cholesterol diet. (A) Male mice were fed a 2%
cholesterol diet for 4 months (12–30 weeks) and then sacrificed (n=5). (B) HE staining of the liver (sets at the upper and lower left). The arrows
indicate eosin-negative foci which with autofluorescence (lower right: red, and nuclei are blue (DAPI)). The magnification is the same in each set. (C)
Cholesterol and TG levels in the liver and serum were measured (n=5). *** indicates p,0.001. Means and SEM are shown. (D) FPLC analysis of serum
lipids. (E) Serum levels of alanine aminotransferase (ALT) were monitored at the indicated time points. * and ** indicate p,0.05 and p,0.01,
respectively. (F) Quantitative polymerase chain reaction analysis of inflammatory molecules in the liver.
doi:10.1371/journal.pone.0037803.g005
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metabolism [42], resulting in the proliferation of bile duct
epithelial cells (Figure 4B) [43]. Moreover, the livers of Sik3
2/2
mice expressed lower levels of RxramRNA than the livers of wild-
type mice, when the mice were fed with diets rich in cholesterol or
CA (Figure S4B). Therefore, we decided to examine vitamin A
metabolism in the livers of Sik3
2/2 mice by quantifying mRNA
and protein levels.
The mRNA and protein levels of cellular retinoid-binding protein 1
(Crbp1) and retinal aldehyde dehydrogenase 1a (Aldh1a) were up- and
down-regulated, respectively, in Sik3
2/2 mice (Figure S4C and
8B). Aldh1a mRNA levels in the livers of Sik3
2/2 mice were also
unaffected by the diet (Figure 8C). In addition, the livers of Sik3
2/
2 mice contained higher levels of free retinol (vitamin A) than the
livers of wild-type mice (Figure 8D). Moreover, treatment with 9-
cis-RA rapidly reduced the levels of free retinol in the livers of
Sik3
2/2 mice compared to the wild-type mice, suggesting that
vitamin A metabolism might be impaired in Sik3
2/2 mice.
To further characterize these findings, the mice were treated
with 9-cis-RA for 7 days, and several phenotypic parameters were
then examined. Because 9-cis-RA is a pleiotropic compound, we
first determined the minimum dose of 9-cis-RA as
4m gk g
21?day
21 by monitoring the body weight and blood
glucose levels of wild-type mice (Figure S5A and B). Treatment
with 9-cis-RA induced weight gain in Sik3
2/2 mice (Figure 8E)
and enabled them to maintain their blood glucose levels after
fasting (Figure 8F). In addition, 9-cis-RA substantially decreased
the levels of serum ALP and bile acid in Sik3
2/2 mice (Figure
S5C). Sik3
2/2 mice treated with 9-cis-RA were also able to
respond to nutritional stress by inducing the expression of
metabolic markers (compare Figure 8G to 8A and Figure S5D).
These results suggest that impaired vitamin A metabolism might
be a cause of the phenotypes of Sik3
2/2 mice.
Discussion
Here, we have shown that SIK3 is induced in the liver when
mice are fed a diet rich in fat, sucrose, and cholesterol. Sik3
2/2
mice present with a malnourished phenotype due to their reduced
adaptation to excess nutrition, especially to cholesterol and CA,
Figure 6. Excess bile acids in the serum and liver of Sik3
2/2 mice. (A) The serum levels of ALT, alkaline phosphatase, and bile acids are shown.
The age at serum collection of the mice fed a chow diet (n=4–6) are shown, while those of mice fed an HF, HChol, or HF/HS/HChol diet (n=5–6) was
30 weeks (feeding 12–30 weeks). @ in the ALT panel indicates the maximum values for the results shown in Figure 4E. (B) Bile acids were extracted
from the liver (n=3) and normalized by liver weigh. (C) Gain of body weight after feeding mice with a high cholic acid (CA)-containing diet. Wild type
(n=6) and Sik3
2/2 mice (n=5) were fed a diet supplemented with 0.25% CA for 1 month. For the control group, wild-type mice (n=9) were fed with
a chow diet.
doi:10.1371/journal.pone.0037803.g006
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continuously observed even after 10 generations of cross-breeding
with normal C57BL/6J mice, and we observed no substantial
difference between males and females in their response to biased
diets. Given these results, we propose that SIK3, in combination
with vitamin A metabolism, is a novel regulator of cholesterol-BA
homeostasis and lipid-storage size (Figure 9).
Previous studies suggested a direct contribution of RXR to
cholesterol-BA homeostasis. Because the RXR ligand 9-cis-RA is
synthesized from vitamin A, which is absorbed from enterocytes
Figure 7. Sik3
2/2 mice are less tolerant to a cholic acid (CA)-containing diet. (A) Mice (n=6, but Sik3
2/2 mouse died before 1 month) were
fed a diet supplemented with 0.25% cholic acid for 1 month (12–16 weeks) and then sacrificed. (B) HE staining of the liver (left), BSEP staining (right:
BSEP is green and nuclei are blue (DAPI)). The magnification is the same in each set. (C) Photographs of gallbladders (scale, 1 mm). (D) The color of
bile juice and bile sand in the gallbladder. (E) HE staining of the gallbladder. The magnification is the same in both panels. (F) The levels of bile acid
(BA), cholesterol (Chol), and phospholipids (PL) in bile juice from the gallbladder were measured. * and ** indicate p,0.05 and ,0.01, respectively.
Means and SEM are shown. (G) Serum BA and alanine aminotransferase (ALT) levels were monitored at the indicated periods. All ALT data points are
p,0.001, except day 0. (H) Serum alkaline phosphatase (ALP) and total bilirubin (T-Bil) levels were measured. (I) Cholesterol and TG levels in the liver
and serum were measured. *** indicates p,0.001. (J) FPLC analysis of serum lipids.
doi:10.1371/journal.pone.0037803.g007
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homeostasis [44]. A lack of vitamin A stimulates BA synthesis and
its transport from hepatocytes to the bile ducts, e.g., via Cyp7a and
Bsep gene expression [45], while excess 9-cis-RA inhibits their
expression. The reduced expression of ALDH1a, an RA synthase,
in the livers of Sik3
2/2 mice might be one of the causes of the
Sik3
2/2 phenotype. All-trans-RA suppresses the expression of
Aldh1a via an RAR-dependent mechanism [46], but 9-cis-RA does
not, suggesting a distinct action for 9-cis-RA from all-trans-RA.
Because physiological/endogenous 9-cis-RA has been identified
only in the pancreas [47,48], analyses of not only 9-cis-RA, but
also its related substances in the liver are required to precisely
characterize the Sik3
2/2 phenotype.
The administration of 9-cis-RA to Sik3
2/2 mice recovered the
expression of Cyp7a and Bsep (Figure 7A and 7G), suggesting that
the dose used (4 mg kg
21?d
21) may not be excessive for Sik3
2/2
mice. However, we have to mention that the wild-type mice that
were fed with a vitamin A-deficient diet for 6 months from
weaning did not develop cholestasis (unpublished observation),
indicating that the levels of vitamin A and its metabolites may be
insufficient to explain all of the Sik3
2/2 phenotypes. Meanwhile,
free retinol (vitamin A) accumulated in the livers of Sik3
2/2 mice.
Vitamin A toxicity is also suspected in hepatic cholestasis [49],
suggesting that increased levels of free retinol may also contribute
to the dysregulation of cholesterol-BA homeostasis in Sik3
2/2
mice. In addition, retinol aldehyde, a substrate of ALDH1a and a
precursor of RA, is found to possess strong anti-obesity actions in
mice [10].
Meanwhile, the high-fat diet ameliorated cholestasis in Sik3
2/2
mice (Figure 6A) without FA storage (in the liver and adipose
tissues) or restoring the mRNA levels of genes involved in FA
synthesis, such as Fasn (Figure 2 and Table S1). Interestingly, the
high-fat diet up-regulated the expression of thiolase, a PPARa
target, in the livers of Sik3
2/2 mice. PPARa is known to enhance
bile flow [50] and some transcriptional pathways, such as Shp [51]
(and also compare Table S1 to Figure 3A). Given that RXR is
required for PPARa activation, its signaling may also be impaired
in Sik3
2/2 mice, as expected from the gene expression profile
observed for the chow diet (Figure 3A). These observations suggest
that excess fat may stimulate a part of the downstream PPARa
Figure 8. Impairment of cholesterol and bile acid (BA) metabolic gene regulation in Sik3
2/2 mice. (A) Male mice (12 weeks of age, n=3)
were fed diets supplemented with cholesterol (2%) and cholic acid (CA) (0.25%) for 2 days or with fat (60% of calories) for 2 weeks and then sacrificed.
The expression of genes for cholesterol and BA metabolism in the liver was examined using qPCR (normalized by glyceraldehyde 3-phosphate
dehydrogenase [Gapdh] levels). Significant differences between wild-type and Sik3
2/2 mice are shown by *, **, and *** for p,0.05, ,0.01, and
,0.001, respectively. # indicates significant differences between the chow and special diet groups. Means and SEM are shown. (B) Western blot
analysis of ALDH1a and CRBP1 levels. (C) The levels of Aldh1a mRNA in mouse liver (normalized by Gapdh levels). (D) Levels of free retinol (vitamin A)
in the livers of wild-type and Sik3
2/2 mice. Mice (12 weeks of age, n=3) were treated with (+) or without (2) 9-cis-RA (8.3 mg/kg, suspended in 1%
ethanol) intraperitoneally. After 6 h, the liver was recovered. (E) Mice (wild type, n=4; Sik3
2/2 mice, without and with treatment, n=4 and n=12,
respectively) were treated with 9-cis-RA (4 mg kg
21?d
21) for 7 days and the weight gain during this period is shown. * indicates a significant
difference in the Sik3
2/2 groups. (F) After 7 days of treatment, the mice in each group were fasted and their blood glucose levels were monitored.
Significance was calculated in the Sik3
2/2 groups. (G) At day 7, the Sik3
2/2 mice that were treated with RA were grouped into sets of 3 (n=4) and fed
a chow, high-cholesterol, or high-CA diet for a further 2 days under continuous RA treatment; mRNA levels in the liver were then examined.
Significant differences between the chow and special diet groups are indicated.
doi:10.1371/journal.pone.0037803.g008
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impaired in Sik3
2/2 mice), which can improve BA homeostasis,
probably in an SIK3-independent manner.
AMPK-related kinases are activated by the upstream kinase
LKB1 [29,52] SIK3 or AMPK–which kinase is important for the
LKB1-mediated suppression of gluconeogenesis in the liver? Loss
of LKB1 in the liver enhances the gluconeogenic program [53].
Since the gluconeogenic program in LKB-defective mice is
resistant to the AMPK activator metformin, AMPK is proposed
to be the kinase responsible for the LKB1-mediated regulation of
gluconeogenesis. However, the livers of Sik3
2/2 mice possessed
activated AMPK and an enhanced gluconeogenic program
(Figure 3B), suggesting that loss of LKB1 causes a deficiency of
SIK3 and subsequent AMPK resistance. In addition to gluconeo-
genesis, liver-specific LKB-defective mice present with severe
cholestasis due to a lack of BSEP membrane-localization in the
liver [54], while the apical side of the dilated canalicular structure
was positive for BSEP in the livers of Sik3
2/2 mice, suggesting that
the cause of cholestasis in these mice may not be identical to that
in LKB-defective mice. We would again emphasize that the high-
fat diet ameliorated cholestasis in Sik3
2/2 mice, indicating the
importance of the process for nutrients rather than developmental
defects in BA transportation.
Two recent reports have provided an argument against
mechanisms by which SIK3 regulates energy balance. Mihalova
et al. found that class 2a HDACs activated the FOXO
transcription factor via deacetylation, thereby up-regulating
gluconeogenesis in the liver [37]. Conversely, Wang et al. reported
that loss of SIK2 in Drosophila (by disrupting the fly’s Sik3 gene)
resulted in the dephosphorylation of HDAC4 and the subsequent
activation of FOXO [28]. Activated FOXO induces the lipolytic
programs that reduce the lipid levels in body fat, thereby rendering
the fly vulnerable to starvation. These data suggest that
disinactivation of class 2a HDACs followed by the constitutive
activation of FOXO may be a cause of the phenotypes of Sik3
2/2
mice.
Conversely, Crebbp
+/2 mice, with a mutant allele of the histone
acetylase CREB-binding protein, displayed a phenotypes similar
to that of Sik3
2/2 mice, e.g., lipodystrophy, increased glucose
tolerance, resistance to diet-induced obesity, and hyperadiponec-
tinemia [55], suggesting that SIK3 may regulate energy balance by
regulating acetylation states. The levels of adipose tissue and
circulating blood lipids may be important for buffering cholesterol
and protecting the liver from cholesterol toxicity, which in turn,
increases the risk of obesity and hyperlipidemia (Figure 9).
In the present study, profiling the metabolic changes in Sik3
2/2
mice represents a new start to the study SIK and may also provide
novel insights into the metabolic diseases caused by Western diets.
Another remarkable phenotype of Sik3
2/2 mice is found in the
differentiation of chondrocytes [31], and a number of interactions
between energy metabolism and skeletal development have been
reported, e.g., insulin [56], leptin [57], adiponectin [58], osteocal-
cin [59,60], and inflammatory cytokines [61]. Further analyses of
the cell autonomous functions of SIK3 and of systemic or
developmental abnormalities in the organs for energy metabolicsm
in Sik3
2/2 mice are needed.
Materials and Methods
Sik3
2/2 Mice
Embryonic stem cells derived from a C57BL/6N strain
(RENKA) were used with the Sik3
2/2 mice. After mating the
mice with C57BL/6J mice (CLEA Japan, Tokyo, Japan) for 3
generations, mouse colonies were expanded for experiments under
chow and high-fat-diet feeding. After 7 generations of cross
breeding, mice colonies were used for cholesterol and cholic acid
experiments. Sik3
+/2 mice are now supplied by JCRB Laboratory
Animal Resource Bank at the National Institute of Biomedical
Innovation (No. nbio157). The experimental mouse protocols
were approved by the ethics committee at the National Institute of
Biomedical Innovation (assigned No. DS-20-56). The animals
were maintained under standard conditions of light (0800–2000)
and temperature (23uC, 50% humidity).
For tissue isolation, all mice were fasted for 4 h and then
sacrificed within 61 h of lights out. The chow diet, MF, was
purchased from Oriental Yeast (Tokyo, Japan). The high-sucrose
(20% cal), high-fat (60% cal), and high-fat (45% cal)/high-sucrose
Figure 9. Summary of the metabolic events in wild-type (upper)
and in Sik3
2/2 mice (lower).
doi:10.1371/journal.pone.0037803.g009
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USA). We supplemented 2% cholesterol in the high-fat and high-
fat/high-sucrose diets. To prepare the high-cholesterol and high-
cholic acid (CA) diets, the chow diet was supplemented with 2%
cholesterol or 0.25% CA, respectively. O2 consumption was
monitored using the Oxymax system (Columbus Instruments,
Columbus, OH, USA).
The pre-fasting periods for the glucose tolerance test (GTT),
insulin tolerance test (ITT), and lactate tolerance test (LTT) were
4, 2, and 24 h, respectively. We administered 1.5 g/kg glucose,
36 mg/kg insulin, and 1.5 g/kg lactate intraperitoneally for these
tests, respectively.
Fractionation of Hepatic Parenchymal Cells and Non-
parenchymal Cells
Under anesthesia by isoflurane, female C57BL/6J mice (12-
week-old) were perfused with Hank’s balanced salt solution
containing 0.5 mM EGTA via inferior vena cava followed by
perfusion with Liver Digestion Medium (Invitorgen). After the
digestion, hepatic cells were suspended in Dulbecco’s Modified
Eagle Medium (DMEM) supplemented with 10% fetal bovine
serum and centrifuged at 406g for 2 minutes. The pellet was used
for the parenchymal-cell fraction, and the supernatant was
recovered by further centrifuged at 8006g for 5 min and used
for non-parenchymal-cell fraction.
Reagents
Blood glucose and b-hydroxybutyrate were measured using a
G-meter (Arkray, Kyoto, Japan) and Precision Xceed (Abbott,
Abbott Park, IL, USA), respectively. Total cholesterol and
triglyceride (TG) in sera were measured using a DryChem7000
(Fujifilm, Tokyo, Japan). Lipids in the liver or feces were
extracted in 10 volumes of methanol:chloroform (1:2), dried
under N2 gas, suspended in 300 mL t-butyl alcohol:methanol:-
Triton-X 100 (2:1:1, v/v), and quantified using kits (WAKO,
Osaka, Japan). Serum insulin, leptin and adiponectin levels were
measured using enzyme-linked immunosorbent assay kits from
Shibayagi (Gunma, Japan), and low levels of insulin were
measured with a low range kit from Morinaga (Tokyo, Japan),
while free FA and BA levels were measured using kits from
WAKO. Serum lipid separation by fast protein liquid chroma-
tography (FPLC) was contracted to LipiSEARCH (Skylight
Biotech, Akita, Japan). The anti-AMPK, anti-phospho-AMPK,
and anti-HDAC5 antibodies were purchased from Cell Signal-
ing (Boston, MA, USA), anti-BSEP antibody were from
ABGENT (San Diego, CA, USA), while the anti-ALDH1a
and anti-CRBP1 antibodies were obtained from Epitomics
(Burlingame, CA, USA). The anti-CRTC2 antibody was
described previously [29].
Quantitative Real-time PCR
Total RNA was extracted using an EZ1 RNA Universal Tissue
Kit (Qiagen, Venlo Park, Netherlands), and cDNA was synthe-
sized using a Transcriptor cDNA First Strand Synthesis Kit
(Roche, Branford, CT, USA). PCR amplification was performed
using Platinum Quantitative PCR SuperMix (Invitrogen). Since
the level of the internal standard RNA, 36B4, was induced by the
CA-rich diet, the expression levels of mRNA in the liver of mice
fed with diets supplemented with CA or Chol were normalized
using glyceraldehyde 3-phosphate dehydrogenase levels. Gene
names, abbreviations and primer sequence used in the quantities
PCR analysis are listed in Table S2.
Statistical Analysis
Student’s t-test was used to assess all experimental data in
Microsoft Excel. The mean and standard error of the mean (SEM)
are shown.
Supporting Information
Figure S1 (A) Most Sik3
2/2 mice died on the first day after
birth. The mating system and time of genotyping are indicated.
The percentage and number of mice in the first column indicate
the sum of neonates at day 1 and embryos at E17.5–E18.5.
Neonates prepared by in vitro fertilization were delivered by
cesarean section and living mice were counted without genotyping.
However, ,50% of the mice disappeared by the second day,
probably because they were eaten by the foster mice. (B) The
difference in the body size of Sik3
2/2 mice became obvious after 2
weeks. (C) HE staining of gonadal fat of 1-year-old mice. (D)
Cholesterol (Chol), triglyceride (TG), and carbohydrate (Carbo)
content in feces (from 3 cages). Cholesterol and triglycerides were
extracted with methanol/chloroform as described in the Materials
and Methods. To extract undigested carbohydrates, the feces were
re-digested with amylase at 37uC for 12 h, and the debris was
removed by centrifugation. Carbohydrates were stained with a
solution of 1 volume of 5% phenol and 5 volumes of sulfuric acid
and then detected at 490 nm. (E) After fasting for 4-h fasting, the
serum levels of free thyroid hormones (FT3 and FT4) were
measured with an automated system for clinical assays. Serum
thyroid stimulating hormone (TSH) levels were measured with an
ELISA kit from Shibayagi Co., Ltd. (F) Insulin tolerance test
(ITT). Mice (male n=5) were fasted for 2 h and then treated
intraperitoneally with 36 mg/kg insulin. All data points are
p,0.001.
(TIF)
Figure S2 (A) Body weight curves of wild-type and Sik3
heterozygous mice are also shown (n =12). (B) Levels of Sik3
mRNA in the livers, brown adipose tissues (BAT), and muscles of
wild-type, heterozygous, and Sik3
2/2 mice (n=3). The error bars
indicate SEM. Levels of SIK3 protein in the livers of wild-type,
heterozygous, and Sik3
2/2 mice. (C) Hepatic parenchymal and
non-parenchymal cells were separated by centrifugation, and Sik3
mRNA levels were examined by quantitative PCR. Cyp7a, F4/80,
and Desmin were used as markers for parenchymal cells, Kupffer’s
cells (non-parenchymal), and hepatic stellate cells (non-parenchy-
mal), respectively. (n=3: means and SEM are shown). (D) In vitro
adipocyte differentiation assay. Preadipocytes were prepared from
gonadal fat pads using collagenase and then plated. When the cells
reached confluence, the culture medium was changed to
Dulbecco’s Modified Eagle’s Medium (high glucose) supplemented
with rosiglitazone (Rosi: indicated concentration), and insulin
(1 mg/mL). After 8 days (with changes of medium every 2 days),
the cells were fixed with 4% paraformaldehyde and stained with
Oil Red O. The high magnification images show cells that were
differentiated using 3 mM rosiglitazone. (F) Serum adiponectin
levels of the mice examined in Figure 3E. Means and SEM are
shown. ### indicates p,0.001.
(TIF)
Figure S3 (A) HE staining of embryo livers. The sets in the left
and right panels are the same magnification. The lower panels are
a higher magnification of the upper panels. (B) Bile acid was
extracted with 95% ethanol/0.5% NH3-water. The numbers of
mice (wild-type and Sik3
2/2) used for the assay were: E16.5, 11
and 6; E18.5, 16 and 3; P0, 9 and 5; and 12 weeks, 8 and 5,
respectively. Means and SEM are shown. Significant differences
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2/2 mice are shown by * for p,0.05.
## indicates significant differences between P0 and E18.5 or 12
weeks in wild-type mice (p,0.01).
(TIF)
Figure S4 (A) Male mice (12 weeks of age, n=3) were fed diets
supplemented with Chol (2%) and cholic acid (0.25%) for 2 days
or with fat (60% of calories) for 2 weeks and then sacrificed. The
expression of genes for Chol and BA metabolism in the liver was
examined using quantitative polymerase chain reaction (normal-
ized by glyceraldehyde 3-phosphate dehydrogenase [GAPDH]
levels). Significant differences between wild-type and Sik3
2/2 mice
are shown by *, **, and *** for p,0.05, ,0.01, and ,0.001,
respectively. # indicates a significant difference between the chow
and special diet groups. Means and SEM are shown. (B)
Expression levels of nuclear receptors. (C) The expression of
genes involved in vitamin A metabolism was examined using the
liver cDNA in Figure 3A (1-year-old mice, n=5).
(TIF)
Figure S5 (A) Effect of 9-cis-RA treatment (0–16 mg kg
21?d
21)
on the weight gain of wild-type mice (n=6). (B) Blood glucose
levels before and after treatment are indicated by labels as B and
A, respectively. (C) The levels of serum ALP and bile acids were
measured before (labeled as B) and after (labeled as A) 9-cis-RA
treatment (for 9 days: after the analysis shown in Figure 8E).
Ethanol (EtOH, 1%) was used as a solvent. Significant differences
before and after treatment in the same group (n=4) are indicated.
Although there were no significant fluctuations in the levels of bile
acids, their levels decreased in all Sik3
2/2 mice after treatment.
(D) Effect of 9-cis-RA on gene expression in Sik3
2/2 mice. At day
7, Sik3
2/2 mice treated with 9-cis-RA were grouped into sets of 3
(n=4) and fed a chow, high-Chol, or high-CA diet for an
additional 2 days under continuous RA treatment; mRNA levels in
the liver were then examined. Significant differences between the
chow and special diet groups are indicated.
(TIF)
Table S1 mRNA levels in the liver.
(XLS)
Table S2 List of primers used for quantitative-PCR.
(XLS)
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